TyriAb is a biotechnology venture focused on antibody research, development, and local manufacturing to strengthen Saudi Arabia’s scientific and healthcare ecosystem. We aim to reduce dependence on imported antibodies by delivering high quality locally produced solutions with faster lead times, competitive pricing, and reliable supply.

By combining advanced recombinant antibody technologies with scientific expertise, TyriAb serves universities, research hospitals, diagnostic laboratories, and strategic national buyers. Our products are designed to meet real laboratory needs through flexible formats, custom solutions, and demand driven innovation.

Aligned with Saudi Vision 2030, TyriAb supports economic diversification, healthcare resilience, local manufacturing, and regional biotech leadership. We are building the future of life sciences in the Kingdom — starting with antibodies.